VIDEO

FindCenter AddIcon

Amanda Feilding: From Taboo to Treatment: The Coming of Age of Psychedelic Medicine

By Amanda Feilding — 2017

23:31 min

47:46

Robert Jesse: Psilocybin Occasions Mystical Experiences Having Sustained Spiritual Significance

Robert Jesse is the organiser of the Council on Spiritual Practices, which aims to shift modernity's awareness and practices with respect to primary religious experience.

FindCenter AddIcon
58:39

MINDSET Lecture Series: Natalie Ginsberg, MSW

Natalie Ginsberg, MSW, discusses ayahuasca and the healing potential of psychedelics for intergenerational trauma in the Palestinian-Israeli conflict.

FindCenter AddIcon
50:07

Ann and Sasha Shulgin - Pihkal and Tihkal: A Chemical Love Story

"We met, married and formed a research team about twenty five years ago. This called upon a background of psychedelic drug invention and exploration of the previous twenty years, but it added a new dimension to this area of exploration.

FindCenter AddIcon
01:05:36

Race and Psychedelics With Dr. Monnica T. Williams

In this timely webinar - moderated by Chief Psychologist (USA) Dr. Dominique Morisano - clinical psychologist and thought-leader Dr.

FindCenter AddIcon
02:04

Higher Dose Ketamine Infusions to Treat PTSD

PTSD can be very challenging to treat.

FindCenter AddIcon
13:25

Can Ketamine and MDMA Treat Trauma?

This weeks video looks at the effects of MDMA/ecstasy and ketamine as a treatment option for ptsd. The biological mechanisms involved in these drugs for ptsd as well as depression/anxiety are mentioned, as well as the therapeutic benefits and research in the area.

FindCenter AddIcon
27:34

Ketamine Therapy: A Disruptive Treatment Paradigm

Ketamine is a controversial yet effective treatment in psychiatry, and it arrives at a much needed time as depression and suicide rates have reached crisis levels in the United States.

FindCenter AddIcon
51:12

Ketamine, Glutamate, and the Future of Mood Disorders Therapeutics

In this webinar, Dr. Sanjay Mathew will review the history of ketamine for the treatment of serious depressive disorders and other similar treatments in development.

FindCenter AddIcon
57:00

Researching Psychedelics and DMT with Rick Strassman

Here he describes the process of setting up a program to research the psychedelic drug, DMT, at the University of New Mexico. It took two years to obtain the required permissions, as there had been a twenty year hiatus in psychedelic research on human subjects.

FindCenter AddIcon
01:03:04

Christopher Timmermann—the Neurophenomenology of the DMT State

The Neurophenomenology of the DMT State, presented by Christopher Timmermann from Imperial College London, UK

FindCenter AddIcon

EXPLORE TOPIC

Drug Policy